Roshan PK: Breaking Down Pulmonary Embolism Treatment By Risk Level
Roshan PK, Assistant Professor, Emergency Physician at Government Medical College, posted on LinkedIn:
”Breaking Down Pulmonary Embolism (PE) Treatment by Risk Level
From the 2022 NEJM Review on Pulmonary Embolism – a comprehensive guide by Kahn and de Wit:
Low-Risk PE (Stable, no RV strain or elevated biomarkers):
• Start with oral anticoagulants like apixaban (10mg 2x/day for 7 days, then 5mg 2x/day) or rivaroxaban.
• Outpatient treatment often safe if no other concerns.
• No thrombolysis or embolectomy needed.
• Duration: At least 3 months; longer if high recurrence risk.
Intermediate-Risk PE (Stable but with RV dysfunction or high biomarkers):
• Immediate low-molecular-weight heparin (LMWH) for anticoagulation.
• Hospital monitoring essential – watch for worsening.
• Thrombolysis only if deteriorating (systemic preferred; catheter-directed as alternative).
• Embolectomy if high bleeding risk or near-shock.
• Same duration as low-risk.
High-Risk PE (Unstable with hypotension/shock):
• IV unfractionated heparin + reperfusion therapy.
• Systemic thrombolysis first if no high bleeding risk.
• Surgical or catheter-directed embolectomy if thrombolysis contraindicated or fails.
• Urgent action to stabilize
Remember, risk stratification uses hemodynamics, imaging, and biomarkers. Always seek professional medical advice – this is for info only.”
Stay updated with Hemostasis Today.
-
Oct 21, 2026, 18:13Wolfgang Miesbach: Hereditary Hemorrhagic Telangiectasia An Overlooked Bleeding Disorder
-
Oct 21, 2026, 17:55Gayatri Kotwal։ New Review on Anemia, Pain, and Nutritional Deficiencies in Cancer Patients
-
Oct 21, 2026, 17:40Tetsuzan Ron: Iron Deficiency Without Anemia Clinical Impact and Management
-
Oct 21, 2026, 17:29Amir Hossien Esfandiari։ The Association Between Viral Infections and Aplastic Anemia
-
Oct 21, 2026, 17:16Melissa Hollo: A Meaningful Step Forward for Women’s Health
-
Oct 21, 2026, 17:09Chipili Ng’onga: Have You Ever Seen a Result That Just Didn’t Make Sense?
-
Oct 21, 2026, 16:57Fabrice Cognasse: Celebrating the Next Generation of Platelet Research and Transfusion Medicine
-
Oct 21, 2026, 16:47Christabel Odeta: Treating Pediatric Cancer in Children With Sickle Cell Disease
-
Oct 21, 2026, 16:36Sharlene Haywood: Bringing Multidisciplinary Learning Into Nursing Practice